Removing a snippet of tissue from the body and subjecting it to the right tests can reveal a lot about a person’s disease or disease risk. With a new...
Read More »Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs
AMPEL BioSolutions announced proof-of-principle for a multi-pronged approach to rank small molecules and biologics for safe, effective treatment of patients with Systemic Lupus Erythematosus (SLE) and...
Read More »Researchers use RNA-Seq to answer long-standing question about lupus
BLACKSBURG, Va., Dec. 7, 2015 – For years, biomedical researchers have suspected that a specific set of immune cells are responsible for causing disease in lupus patients, but until now they haven’t known for sure one way or the other. ...
Read More »